ScholarIQanswers from OpenAlex

Retinal disease in the C3 glomerulopathies and the risk of impaired vision

PaperCitations, authors & open-access status

Retinal disease in the C3 glomerulopathies and the risk of impaired vision is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Retinal disease in the C3 glomerulopathies and the risk of impaired vision have?

ScholarIQcitation count

Retinal disease in the C3 glomerulopathies and the risk of impaired vision has 37 citations in the OpenAlex counts ScholarIQ stores.

When was Retinal disease in the C3 glomerulopathies and the risk of impaired vision published?

ScholarIQyear

Retinal disease in the C3 glomerulopathies and the risk of impaired vision has 2016 year in the ScholarIQ index.

What is the open-access status of Retinal disease in the C3 glomerulopathies and the risk of impaired vision?

ScholarIQoa status

Retinal disease in the C3 glomerulopathies and the risk of impaired vision has closed oa status in the ScholarIQ index.

What is the DOI of Retinal disease in the C3 glomerulopathies and the risk of impaired vision?

ScholarIQdoi

The DOI for Retinal disease in the C3 glomerulopathies and the risk of impaired vision is on the source record.

What is the PMID of Retinal disease in the C3 glomerulopathies and the risk of impaired vision?

ScholarIQpmid

The PMID for Retinal disease in the C3 glomerulopathies and the risk of impaired vision is on the source record.

What is the OpenAlex record for Retinal disease in the C3 glomerulopathies and the risk of impaired vision?

ScholarIQopenalex

The OpenAlex for Retinal disease in the C3 glomerulopathies and the risk of impaired vision is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial